Evidence map›Paper›PMID 33035393›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Association of double product and pulse pressure with cardiovascular and all-cause mortality in the LURIC study.

Babak Yazdani, Marcus E Kleber, Gökhan Yücel, Graciela E Delgado, Urs Benck, Bernd Krüger, Winfried März, Bernhard K Krämer

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Seasonal fluctuations of cardiovascular risk markers in patients referred to coronary angiography.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Babak YazdaniFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.ORCID 0000-0001-9222-8958
Marcus E KleberFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.ORCID 0000-0003-0663-7275
Gökhan YücelFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.ORCID 0000-0002-1803-2663
Graciela E DelgadoFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.
Urs BenckFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.
Bernd KrügerFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.
Winfried MärzFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.
Bernhard K KrämerFifth Department of Medicine, University Medical Center Mannheim UMM, Mannheim, Germany.ORCID 0000-0002-1718-2918

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systolic (SBP) and diastolic blood pressure (DBP) and mean arterial pressure (MAP) are risk factors for cardiovascular mortality (CVM). Pulse pressure (PP) is considered as an easily available marker of vascular stiffness and the double product (DP) as a marker of cardiac workload. Therefore, we have examined the predictive value of PP and DP in the Ludwigshafen Risk and Cardiovascular Health study, a monocentric cohort study of 3316 patients referred to coronary angiography. An increase of SBP or PP by 1mmHg increased the risk of CVM with hazard ratios of 1.009 (95% CI, 1.005-1.012) and 1.016 (1.012-1.020), respectively. Increasing DP by 100 mm Hg/min was associated with a 1.010 (1.007-1.013) higher risk of CVM. In patient subgroups with coronary artery disease (CAD) and heart failure (HF), PP and DP predicted CVM better than SBP or MAP. In a multivariate analysis adjusted for sex, BMI, diabetes, eGFR, hazard ratios for CVM for z-standardized PP, DP, SBP, and HR were 1.20, 1.16, 1.12, and 1.14. After adding age to the multivariate analysis, only DP and HR remained significant. We provide evidence that PP and DP are powerful predictors of CVM and all-cause mortality in a CV medium- to high-risk population, especially in patients with CAD and HF. While DP proved to be an independent predictor of cardiovascular and all-cause mortality also in multivariate analysis, PP was no independent predictor in our cohort with widespread antihypertensive treatment (>85%). PP is associated with age, presence of diabetes, obesity, and impaired renal function.

Indexed as

Blood PressureHypertensionAntihypertensive AgentsCohort StudiesHumansRisk FactorsAntihypertensive Agentscardiac workloadcoronary artery diseasedouble productheart failurehypertensionmortalitypulse pressurerate pressure productvascular stiffness

Identifiers

PMID33035393
PMCPMC8030052

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.